107 related articles for article (PubMed ID: 17303973)
1. The coprescription of contraindicated drugs with statins: continuing potential for increased risk of adverse events.
Stang P; Morris L; Kempf J; Henderson S; Yood MU; Oliveria S
Am J Ther; 2007; 14(1):30-40. PubMed ID: 17303973
[TBL] [Abstract][Full Text] [Related]
2. Coprescribing and codispensing of cisapride and contraindicated drugs.
Jones JK; Fife D; Curkendall S; Goehring E; Guo JJ; Shannon M
JAMA; 2001 Oct; 286(13):1607-9. PubMed ID: 11585484
[TBL] [Abstract][Full Text] [Related]
3. Trends in Utilization of Statin Therapy and Contraindicated Statin Use in HIV--Infected Adults Treated With Antiretroviral Therapy From 2007 Through 2015.
Rosenson RS; Colantonio LD; Burkholder GA; Chen L; Muntner P
J Am Heart Assoc; 2018 Dec; 7(24):e010345. PubMed ID: 30526249
[TBL] [Abstract][Full Text] [Related]
4. Risks of Adverse Events Following Coprescription of Statins and Calcium Channel Blockers: A Nationwide Population-Based Study.
Wang YC; Hsieh TC; Chou CL; Wu JL; Fang TC
Medicine (Baltimore); 2016 Jan; 95(2):e2487. PubMed ID: 26765458
[TBL] [Abstract][Full Text] [Related]
5. Rates of Physician Coprescribing of Opioids and Benzodiazepines After the Release of the Centers for Disease Control and Prevention Guidelines in 2016.
Jeffery MM; Hooten WM; Jena AB; Ross JS; Shah ND; Karaca-Mandic P
JAMA Netw Open; 2019 Aug; 2(8):e198325. PubMed ID: 31373650
[TBL] [Abstract][Full Text] [Related]
6. Co-administration of statins with cytochrome P450 3A4 inhibitors in a UK primary care population.
Bakhai A; Rigney U; Hollis S; Emmas C
Pharmacoepidemiol Drug Saf; 2012 May; 21(5):485-93. PubMed ID: 22237927
[TBL] [Abstract][Full Text] [Related]
7. Using a computerized drug prescription screening system to trace drug interactions in an outpatient setting.
Morera T; Gervasini G; Carrillo JA; Benitez J
Ann Pharmacother; 2004; 38(7-8):1301-6. PubMed ID: 15178735
[TBL] [Abstract][Full Text] [Related]
8. An examination of the effect of cytochrome P450 drug interactions of hydroxymethylglutaryl-coenzyme A reductase inhibitors on health care utilization: a Canadian population-based study.
Einarson TR; Metge CJ; Iskedjian M; Mukherjee J
Clin Ther; 2002 Dec; 24(12):2126-36. PubMed ID: 12581550
[TBL] [Abstract][Full Text] [Related]
9. Prescriber acceptance rate of pharmacists' recommendations.
Doellner JF; Dettloff RW; DeVuyst-Miller S; Wenstrom KL
J Am Pharm Assoc (2003); 2017; 57(3S):S197-S202. PubMed ID: 28408169
[TBL] [Abstract][Full Text] [Related]
10. Statin-macrolide interaction risk: a population-based study throughout a general practice database.
Piacentini N; Trifiró G; Tari M; Moretti S; Arcoraci V;
Eur J Clin Pharmacol; 2005 Sep; 61(8):615-20. PubMed ID: 16044339
[TBL] [Abstract][Full Text] [Related]
11. Underutilization of high-intensity statin therapy after hospitalization for coronary heart disease.
Rosenson RS; Kent ST; Brown TM; Farkouh ME; Levitan EB; Yun H; Sharma P; Safford MM; Kilgore M; Muntner P; Bittner V
J Am Coll Cardiol; 2015 Jan; 65(3):270-7. PubMed ID: 25614424
[TBL] [Abstract][Full Text] [Related]
12. Coprescription of triptans with potentially interacting medications: a cohort study involving 240,268 patients.
Tepper S; Allen C; Sanders D; Greene A; Boccuzzi S
Headache; 2003 Jan; 43(1):44-8. PubMed ID: 12864757
[TBL] [Abstract][Full Text] [Related]
13. Physicians' prescribing attitudes to combined therapy with statins and fibrates.
Takada M; Demizu M; Shibakawa M
J Clin Pharm Ther; 2003 Dec; 28(6):445-50. PubMed ID: 14651665
[TBL] [Abstract][Full Text] [Related]
14. Association of Primary Care Providers' Beliefs of Statins for Primary Prevention and Statin Prescription.
Clough JD; Martin SS; Navar AM; Lin L; Hardy NC; Rogers U; Curtis LH
J Am Heart Assoc; 2019 Feb; 8(3):e010241. PubMed ID: 30681391
[TBL] [Abstract][Full Text] [Related]
15. Statin toxicity from macrolide antibiotic coprescription: a population-based cohort study.
Patel AM; Shariff S; Bailey DG; Juurlink DN; Gandhi S; Mamdani M; Gomes T; Fleet J; Hwang YJ; Garg AX
Ann Intern Med; 2013 Jun; 158(12):869-76. PubMed ID: 23778904
[TBL] [Abstract][Full Text] [Related]
16. Incidence of potential drug interactions in co-prescription of statins and macrolide antibiotics in Croatia during the 14 year period.
Grgurević D; Grgurević J; Vrca VB; Marušić S; Marinović I; Grgurević AB
Pharmazie; 2021 Jun; 76(6):272-278. PubMed ID: 34078522
[TBL] [Abstract][Full Text] [Related]
17. Patterns of statin utilisation for new users and market dynamics in South Korea: a 13-year retrospective cohort study.
Son KB; Bae S
BMJ Open; 2019 Mar; 9(3):e026603. PubMed ID: 30842117
[TBL] [Abstract][Full Text] [Related]
18. Prescribing of contraindicated protease inhibitor and statin combinations among HIV-infected persons.
Hulgan T; Sterling TR; Daugherty J; Arbogast PG; Raffanti S; Ray W
J Acquir Immune Defic Syndr; 2005 Mar; 38(3):277-82. PubMed ID: 15735444
[TBL] [Abstract][Full Text] [Related]
19. Prescriber compliance with black box warnings in older adult patients.
Ricci JR; Coulen C; Berger JE; Moore MC; McQueen A; Jan SA
Am J Manag Care; 2009 Nov; 15(11):e103-8. PubMed ID: 19895180
[TBL] [Abstract][Full Text] [Related]
20. How many "Me-Too" drugs are enough? The case of physician preferences for specific statins.
Austin PC; Mamdani MM; Juurlink DN
Ann Pharmacother; 2006 Jun; 40(6):1047-51. PubMed ID: 16705028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
